Stay updated on XMT-1660 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the XMT-1660 in Solid Tumors Clinical Trial page.

Latest updates to the XMT-1660 in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedUI updates include Show glossary / Hide glossary and revised QC-related labels (Last Update Submitted that Met QC Criteria, Last Update Posted). There is also a version change to Revision: v3.4.0.SummaryDifference0.3%

- Check20 days agoChange DetectedRevision: v3.3.4 updates the page version from v3.3.3, a maintenance update with no impact on study details or page functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded a Locations section with state-level site entries (Arizona, California, Florida, etc.). The page revision updated to v3.3.3, and older location subsections were removed.SummaryDifference1%

- Check69 days agoChange DetectedPublication list wording updated to indicate that entries are auto-filled from PubMed and may not all pertain to the study, with a new Revision: v3.3.2 added. The previous language stating PubMed-derived publications are automatically created by ClinicalTrials.gov and the older Revision: v3.2.0 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check77 days agoChange DetectedThe NIH funding/operating status notice on the page has been removed. This does not change the study details or data shown.SummaryDifference0.3%

- Check92 days agoChange DetectedThe Study Details page updates the Contacts and Locations with additional recruiting sites and new investigators, and notes that there are now 26 locations.SummaryDifference2%

Stay in the know with updates to XMT-1660 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XMT-1660 in Solid Tumors Clinical Trial page.